Actualités FutureTech II Acquisition Corporation - FTII | Actions NASDAQ

Outils de qualité professionnelle, pour des investisseurs individuels.

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

New York, New York, Dec. 04, 2024 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (the “Company”) (NASDAQ: FTII), today announced that it...

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

-Longevity Biomedical, Inc. is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health...

Current Report Filing (8-k)

0001889450 false 0001889450 2023-05-17 2023-05-17 0001889450...

FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

New Rochelle, NY, May 17, 2023 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (Nasdaq: FTIIU) (the...

Quarterly Report (10-q)

0001889450 false Q1 --12-31

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G...

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of...

Amended Annual Report (10-k/a)

0001889450 true FY 0001889450 2021-08-19 2021-12-31 0001889450...

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25...

Quarterly Report (10-q)

0001889450 false Q2 --12-31

Quarterly Report (10-q)

0001889450 false Q1 --12-31

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

FutureTech II Acquisition Corporation (FTII)

Outils de qualité professionnelle, pour des investisseurs individuels.

FTII Actualités

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

Current Report Filing (8-k)

FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

Quarterly Report (10-q)

Statement of Ownership (sc 13g)

Statement of Ownership (sc 13g)

Statement of Ownership (sc 13g)

Amended Annual Report (10-k/a)

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

Quarterly Report (10-q)

Quarterly Report (10-q)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

FutureTech II Acquisition Corporation (FTII) Actualités

FutureTech II Acquisition Corporation (FTII)

Outils de qualité professionnelle, pour des investisseurs individuels.

FTII Actualités

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

Current Report Filing (8-k)

FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

Quarterly Report (10-q)

Statement of Ownership (sc 13g)

Statement of Ownership (sc 13g)

Statement of Ownership (sc 13g)

Amended Annual Report (10-k/a)

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

Quarterly Report (10-q)

Quarterly Report (10-q)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application